Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SeaStar Medical
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Informed consent obtained
Positive COVID-19 test
Must be receiving medical care in an intensive care nursing situation
Non-pregnant females
Intent to deliver full supportive care through aggressive management utilizing all available therapies for a minimum of 96 hours.
Platelet count \>30,000/mm3 at Screening
Clinical diagnosis of AKI requiring CRRT or ARDS
You may not be if
Cardiovascular instability that precludes initiation of continuous renal replacement therapy (CRRT).
Irreversible brain damage based on available historical and clinical information.
Presence of any solid organ transplant at any time.
Patients with stem cell transplant in the previous 100 days or who have not engrafted.
Acute or chronic use of circulatory support device other than ECMO such as LVADs, RVADs, BIVADs.
Metastatic malignancy which is actively being treated or may be treated with chemotherapy or radiation during the subsequent three month period after study treatment.
Chronic immunosuppression defined as \>20 mg prednisone qd alone without other immunosuppressant medications (ie (cyclophosphamide, azathioprine, methotrexate, rituximab, mycophenolate, cyclosporine).
Patient is moribund or chronically debilitated for whom full supportive care is not indicated.
Concurrent enrollment in another interventional clinical trial. Patients enrolled in observational studies (NO TEST DEVICE OR DRUG USED) are allowed to participate.
